Institutional Ownership Keros Therapeutics, Inc. (KROS)
This table provides information about the institutional ownership of Keros Therapeutics, Inc. (KROS). We have compiled data on the 177 institutions that hold shares in the stock, with a total of 31.1 Million shares, which have been reported (via 13F filing form) to have a value of $357 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,513,244
shares
|
$29.1 Million
0.0% of portfolio
|
Q2 2024
Added 16.03%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
1,957,109
shares
|
$22.7 Million
0.0% of portfolio
|
Q4 2024
Added 5.42%
|
|
|
Braidwell LP
Stamford, CT |
Feb 14, 2025 Q4 2024 |
1,894,439
shares
|
$21.9 Million
1.68% of portfolio
|
Q4 2024
Added 167.86%
|
|
|
Darwin Global Management, Ltd.
St. Helier, Y9 |
Feb 14, 2025 Q4 2024 |
1,687,135
shares
|
$19.5 Million
2.53% of portfolio
|
Q4 2024
Added 10.72%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,203,383
shares
|
$13.9 Million
0.0% of portfolio
|
Q4 2024
Added 8.06%
|
|
|
Holocene Advisors, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,199,990
shares
|
$13.9 Million
0.07% of portfolio
|
Q4 2024
Added 42.33%
|
|
|
Alkeon Capital Management LLC
New York, NY |
Feb 13, 2025 Q4 2024 |
1,101,000
shares
|
$12.7 Million
0.04% of portfolio
|
Q4 2024
Reduced 41.98%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
1,018,734
shares
|
$11.8 Million
0.44% of portfolio
|
Q3 2024
Reduced 19.7%
|
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Feb 14, 2025 Q4 2024 |
915,048
shares
|
$10.6 Million
0.73% of portfolio
|
Q4 2024
Added 139.76%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
909,707
shares
|
$10.5 Million
0.0% of portfolio
|
Q4 2024
Reduced 39.93%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
878,159
shares
|
$10.2 Million
0.01% of portfolio
|
Q4 2024
Added 53.26%
|
|
|
Jefferies Financial Group Inc.
New York, NY |
Feb 27, 2025 Q4 2024 |
866,737
shares
|
$10 Million
0.09% of portfolio
|
Q3 2024
Reduced 3.6%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
791,109
shares
|
$9.16 Million
0.0% of portfolio
|
Q4 2024
Added 12.23%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
765,436
shares
|
$8.86 Million
0.0% of portfolio
|
Q4 2024
Added 5.49%
|
|
|
Mangrove Partners
New York, NY |
Feb 14, 2025 Q4 2024 |
736,385
shares
|
$8.53 Million
1.82% of portfolio
|
Q4 2024
Added 156.58%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
656,801
shares
|
$7.61 Million
0.0% of portfolio
|
Q4 2024
Added 79.8%
|
|
|
Redmile Group, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
552,506
shares
|
$6.4 Million
0.68% of portfolio
|
Q1 2024
New holding
|
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Feb 14, 2025 Q4 2024 |
550,000
shares
|
$6.37 Million
1.42% of portfolio
|
Q4 2024
Reduced 37.45%
|
|
|
Lynx1 Capital Management LP
San Juan, PR |
Feb 14, 2025 Q4 2024 |
544,001
shares
|
$6.3 Million
3.34% of portfolio
|
Q4 2024
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
535,584
shares
|
$6.2 Million
0.0% of portfolio
|
Q4 2024
Added 50.59%
|
|
|
Integral Health Asset Management, LLC
|
Feb 14, 2025 Q4 2024 |
450,000
shares
|
$5.21 Million
0.64% of portfolio
|
Q4 2024
Added 125.0%
|
|
|
Chi Advisors LLC
New York, NY |
Nov 13, 2023 Q3 2023 |
407,633
shares
|
$4.72 Million
6.41% of portfolio
|
Q3 2023
Added 1.37%
|
|
|
Catalio Capital Management, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
407,292
shares
|
$4.72 Million
1.41% of portfolio
|
Q4 2024
New holding
|
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
387,701
shares
|
$4.49 Million
0.05% of portfolio
|
Q4 2024
Reduced 49.22%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
380,000
shares
|
$4.4 Million
0.12% of portfolio
|
Q3 2024
Reduced 23.88%
|